
106.90 BATS BZX Real-Time Price As of 11:06am ET | ![]() Today’s Change | 75.25 Today|||52-Week Range 129.29 | -10.50% Year-to-Date |
The 24 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 131.00, with a high estimate of 165.37 and a low estimate of 101.00. The median estimate represents a +22.54% increase from the last price of 106.90.
The current consensus among 27 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.